Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Equity

Seres Therapeutics (MCRB) Debt Ratio (2019 - 2024)

Seres Therapeutics (MCRB) has disclosed Debt Ratio for 7 consecutive years, with 0.32 as the latest value for Q2 2024.

  • Quarterly Debt Ratio rose 28.51% to 0.32 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was 0.32 through Jun 2024, up 28.51% year-over-year, with the annual reading at 0.28 for FY2023, 95.22% up from the prior year.
  • Debt Ratio hit 0.32 in Q2 2024 for Seres Therapeutics, up from 0.3 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.32 in Q2 2024 to a low of 0.04 in Q3 2021.
  • Historically, Debt Ratio has averaged 0.17 across 5 years, with a median of 0.17 in 2022.
  • Biggest five-year swings in Debt Ratio: plummeted 71.41% in 2021 and later surged 300.97% in 2022.
  • Year by year, Debt Ratio stood at 0.07 in 2020, then dropped by 3.34% to 0.07 in 2021, then soared by 108.87% to 0.15 in 2022, then skyrocketed by 95.22% to 0.28 in 2023, then grew by 12.5% to 0.32 in 2024.
  • Business Quant data shows Debt Ratio for MCRB at 0.32 in Q2 2024, 0.3 in Q1 2024, and 0.28 in Q4 2023.